- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
TheStreet reporter Scott Eden updates the latest developments in controversial Chinese reverse mergers.
NEW YORK (TheStreet) -- Scott Eden discusses the troubled Chinese reverse-merger stock Duoyuan Printing, which released an update on its financials Monday.
NEW YORK (TheStreet) -- Reporter Scott Eden examines Duoyuan Printing's disclosure that the SEC has been investigating the company for fraud and what is likely to happen to the stock going forward.
NEW YORK (TheStreet) -- Reporter Scott Eden details what about recent data on China's steel sector has some concerned that a slowdown is on the horizon.
Caterpillar's January sales jumped 49%, but the company's seeing slowing growth in Asian business. Reporter Scott Eden discusses whether investors should buy into Caterpillar as a China play.
NEW YORK (TheStreet) -- Investigation by TheStreet surfaces regulatory failures.
NEW YORK (TheStreet) -- One pro suggests that average investors are not equipped to analyze prospects for small companies in China. The answer: Stay away.
NEW YORK (TheStreet) -- Richard Heckmann says stock cheats in China tricked him with phony customers and sales.
Charles Neivert, the chemicals and agricultural analyst at Dahlman Rose, tells TheStreet why Methanex is his favorite stock in the chemicals sector.
Charles Neivert, the chemicals and agricultural analyst at Dahlman Rose, tells TheStreet what BHP Billiton needs to do to get a deal done with Potash.